Building the Leadership Infrastructure Behind Biotech of the Year 2025
When Greywolf Therapeutics built its own capabilities and left the Molecule to Medicine ecosystem, it was a pivotal moment in the company’s evolution. With pioneering antigen modulation technology designed to empower T cells against disease, Greywolf is on a mission to deliver a new therapeutic class of treatments to help people living with cancers and autoimmune disorders.
Building the Leadership Infrastructure Behind Biotech of the Year 2025
To deliver on the ambition of independent growth, they needed more than scientific excellence. It required a robust operational foundation and senior leaders capable of building it.
Greywolf partnered with Practicus to support the rapid build-out of core business functions across Finance, Quality, IT, Governance, Data and People.
The Challenge:
Scaling at pace, without compromise, transitioning into a standalone biotech organisation meant establishing fully operational business functions while maintaining momentum.
Greywolf needed to:
- Appoint senior leadership across multiple functions simultaneously
- Source niche biotech talent with sector-specific expertise
- Ensure cultural alignment within a high-growth, innovation-led environment
- Balance strategic oversight with hands-on delivery
Each hire would play a defining role in shaping the organisation’s future capability.
Our Approach
With deep experience across life sciences and biotech, we understood that cultural alignment and industry knowledge would be just as critical as technical expertise.
After receiving multiple roles, we acted immediately, reaching out to our UK-wide network of senior life sciences professionals and conducting detailed market research to inform a bespoke headhunting strategy for each role.
Rather than simply presenting opportunities to our network, we positioned Greywolf’s vision, providing candidates with meaningful context around the company’s separation, growth plans and long-term trajectory. This ensured early alignment on both capability and cultural fit.
Shortlisted candidates were carefully selected for their ability to operate at senior level while remaining hands-on during a period of operational build. Each profile was presented with detailed insight into how their experience would directly support Greywolf’s strategic objectives.
The Outcome: A Platform for Accelerated Growth
All roles were successfully filled, enabling Greywolf to build independent operational capability at a rapid pace.
In 2025, Greywolf was named Biotech of the Year at the Pharma Industry Awards UK, recognition of both its scientific innovation and the strength of the team driving its execution.
Our partnership continues today through both a flexible resource model as well as gaining market insights from our Advisory solution, allowing Greywolf to anticipate future hiring needs and scale leadership capability in line with their ongoing growth plans.
Roles Placed Since 2024
Practicus has successfully delivered both permanent and interim appointments across senior leadership and specialist functions, including:
- Data Management Lead
- Accounts Payable & Payroll Manager
- Head of Quality Operations
- Head of People
- Head of IT
- Contracts & Governance Lead
- Finance Manager
- Internal Legal Counsel
Together, these appointments helped establish the operational base to support the Research, Development and Commercial teams.
Client Testimonial
“Practicus has been my go-to partner for several years and at Greywolf is trusted for consistently delivering exceptional talent that strengthens Greywolf’s distinctive culture and drives execution at the highest level.”
— VP Operations, Transformation & Company Secretary
Grey Wolf Therapeutics